Table 3 Odds ratios for exposures within the COVID-19 cohort for patients who had compared to those who did not have an ED visit on or after June 1, 2020
Exposure (3-month lookback unless otherwise indicated) | Odds Ratio (95% CI) | p value |
|---|---|---|
In-person visit to a PCP (above median) | 1.09 (0.94–1.26) | 0.26 |
Virtual visit to a PCP (above median) | 2.35 (2.05–2.70) | < 0.0001 |
In-person visit to a specialist (above median) | 1.32 (1.15–1.52) | 0.0001 |
Virtual visit to a specialist (above median) | 1.57 (1.22–2.01) | 0.0004 |
Radiation | 1.19 (0.95–1.50) | 0.13 |
Chemotherapy | 1.40 (1.21–1.62) | < 0.0001 |
1 or more prior ED visit (from time of initial cancer diagnosis up to June 1, 2020) | 1.91 (1.68–2.17) | < 0.0001 |
Metastatic cancer stage (at diagnosis) | 1.39 (1.10–1.76) | 0.012 |